期刊文献+

异烟肼通过改变肝脏转运体NTCP和BSEP的表达诱导HepG2细胞损伤 被引量:1

Isoniazid induced injury in HepG2 cells by altering expression of liver transporter NTCP and BSEP
原文传递
导出
摘要 目的:基于Na^+-牛磺胆酸共转运多肽(NTCP)和胆盐输出泵(BSEP)探讨异烟肼(INH)致HepG2细胞损伤的机制。方法:不同浓度异烟肼作用于细胞后:(1)MTT法检测细胞存活率;(2)测定细胞内总胆汁酸(TBA)浓度;(3)Western-blot检测NTCP和BSEP蛋白表达的变化。结果:(1)HepG2细胞存活率随着异烟肼浓度升高而呈剂量依赖性的降低。(2)异烟肼可使细胞内胆汁酸浓度明显升高。(3)异烟肼浓度为6.5,13,26 mmol·L^(-1)时上调了NTCP的表达;异烟肼浓度为52,104 mmol·L^(-1)时使NTCP表达回到正常水平。(4)异烟肼浓度为104 mmol·L^(-1)时明显抑制了BSEP的表达。结论:异烟肼可引起HepG2细胞内胆汁酸升高和细胞毒性,其机制可能与调控NTCP和BSEP的表达有关。 OBJECTIVE To study mechanisms of isoniazid(INH)induced HepG2 cell injury based on Na+-taurcholate cotransporting polypeptide(NTCP)and bile salt export pump(BSEP).METHODS Adding INH to HepG2 cells at different concentrations:MTT was used to test cell vibility;biochemical analysis was used to test total bile acids(TBA)concentration;Western Blot was used to test protein expressions of NTCP and BSEP.RESULTS Cell viability decreased in a concentration dependent manner.INH increased TBA concentration in HepG2 cells.Protein expression of NTCP increased at INH concentrations of 6.5,13 and 26 mmol·L^(-1),and went back to normal level at INH concentrations of 52 and 104 mmol·L^(-1).BSEP protein expression decreased at the INH concentration of 104 mmol L^(-1).CONCLUSION INH induces increased TBA concentration and cytotoxicity in HepG2 cells,which may be correlated with NTCP adjustment and BSEP expression.
出处 《中国医院药学杂志》 CAS 北大核心 2018年第1期18-21,共4页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金青年基金(编号:81503168)
关键词 异烟肼 细胞损伤 HEPG2细胞 NTCP BSEP INH cell injury HepG2 cell NTCP BSEP
  • 相关文献

参考文献4

二级参考文献49

  • 1Conforti A, Leone R, Ghiotto E, et al. Spontaneous reporting of drug related hepatic reactions from two Italy regions (Lombardy and Veneto). Digest Liver Dis, 2000,32 : 716-723.
  • 2Sgro C, Clinard F, Ouazir K, el al. Incidence of drug induced hepatic injuries: a French population based study. Hepatology, 2002,36:451-455.
  • 3Bjornsson E, Olsson R. Outcome and prognostic markers in severe drug - induced liver disease. Hepatology, 2005,42 : 481-489.
  • 4Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002,22: 145- 155.
  • 5Elinav E, Pinsker G, Safadi R, et al. Association between consumption of bcrbalife nutritional supplements and acute hepato-toxity. J Hepatol,2007,47:514-520.
  • 6Schoepfer AM, Engel A, Fattinger K, et al. Herbal does not mean innocuous: ten cases of severe hepatotoxity associated with dietary supplements from herbalife products. J Hepatol,2007,47: 521-526.
  • 7Walkins PB, Seeff LB. Drug-induced liver injury: summary of a single topic clinical research conference. Hepatology,20(16,43:618- 631.
  • 8Andrade RJ, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug induced liver injury: long-term follow-up in a hepatotoxity registry. H epalology, 2006,44 : 1581-1588.
  • 9Zimmerman HJ. Drug induced liver disease. Clin Liver Dis,2000, 4:73-96.
  • 10陈冬裕.甘草酸类药物在药物性肝损伤中的应用[J].海峡药学,2007,19(8):6-9. 被引量:16

共引文献95

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部